SCHEMBL7512464

SCHEMBL7512464

O=C(O)c1ccc(-c2ccc3cc(OCc4ccccc4)c(C45CC6CC(CC(C6)C4)C5)cc3c2)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.53
RARB P10826 7/20 0.44
RARG P13631 7/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
RARA P10276 4/20 0.44
NR1I2 O75469 1/20 0.44
LMNA P02545 1/20 0.44
PGR P06401 1/20 0.44
HSPD1 P10809 1/20 0.44
GOT1 P17174 1/20 0.44
GLRA1 P23415 1/20 0.44
BLM P54132 1/20 0.44
HSPE1 P61604 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
THRB P10828 1/20 0.44
RECQL P46063 1/20 0.44
NR2E1 Q9Y466 1/20 0.44
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7927701 0.93 NR4A2 (0.45) NR4A2RARBRARGMEN1KMT2A
SCHEMBL27426477 0.84 MEN1 (0.37) NR4A2RARBRARGMEN1KMT2A
SCHEMBL7518648 0.84 MEN1 (0.64) NR4A2RARBRARGMEN1KMT2A
SCHEMBL8457461 0.82 RARB (0.48) RARBRARGMEN1KMT2ARARA
SCHEMBL7517611 0.81 MEN1 (0.53) RARBRARGMEN1KMT2ARARA
SCHEMBL8460810 0.81 RARB (0.43) RARBRARGMEN1KMT2ARARA
SCHEMBL7926514 0.81 RARB (0.54) RARBRARGMEN1KMT2ARARA
SCHEMBL8438827 0.80 MEN1 (0.66) RARBRARGMEN1KMT2ARARA
SCHEMBL7929545 0.79 RARB (0.47) RARBRARGMEN1KMT2ARARA
SCHEMBL8457462 0.76 HIF1A (0.47) RARBRARGMEN1KMT2ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1104896-C 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor GALDERMA RECH DERMATOLOGIQUE (FR) 2003-04-09 CN claimed
EP-0854711-B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR GALDERMA RECH DERMATOLOGIQUE (FR) 2002-01-23 EP claimed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US claimed
CN-1203529-A RAR-gamma antagonist ligands or RAR-alpha agonist ligands as apoptosis inhibitors CIRD GALDERMA (FR) 1998-12-30 CN claimed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP claimed
CN-1104896-C 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor GALDERMA RECH DERMATOLOGIQUE (FR) 2003-04-09 CN disclosed
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-6063797-A γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor C.I.R.D. GALDERMA (FR) 2000-05-16 US disclosed
CN-1203529-A RAR-gamma antagonist ligands or RAR-alpha agonist ligands as apoptosis inhibitors CIRD GALDERMA (FR) 1998-12-30 CN disclosed
EP-0658553-B1 Polycyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof CIRD GALDERMA (FR) 1998-11-04 EP disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed
EP-0658553-A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-06-21 EP disclosed